Instituto RosenbuschBUE:ROSE +0.93%39 FCF Margin % is 37.87% as of Dec. 2025, which is 1379% above its 10-year median of 2.56. GuruFocus rates BUE:ROSE with a GF Score™ of 39/100 and a GF Value™ of ARS61.70 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 958 Drug Manufacturers companies, Instituto Rosenbusch ranks better than 60.02% on this metric.
The historical rank and industry rank for Instituto Rosenbusch's FCF Margin % or its related term are showing as below:
BUE:ROSE'
s FCF Margin % Range Over the Past 10 Years
Min: -7.88 Med: 2.56 Max: 7.45
Current: 6.21
During the past 13 years, the highest FCF Margin % of Instituto Rosenbusch was 7.45%. The lowest was -7.88%. And the median was 2.56%.
BUE:ROSE's FCF Margin % is ranked better than 60.02% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs BUE:ROSE: 6.21
Instituto Rosenbusch FCF Margin % Related Terms
Instituto Rosenbusch FCF Margin % Historical Data
* Premium members only.
The historical data trend for Instituto Rosenbusch's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUE:ROSE vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instituto Rosenbusch FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Instituto Rosenbusch's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instituto Rosenbusch (BUE:ROSE) has a FCF Margin % of 37.87% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Instituto Rosenbusch and its competitors. This is 1379% above median its historical median of 2.56. According to the industry distribution chart, Instituto Rosenbusch ranks #383 out of 958 companies in the Drug Manufacturers industry, placing it in the top 40%.
Is Instituto Rosenbusch's FCF Margin % too high?
Instituto Rosenbusch's current FCF Margin % of 37.87% is 1379% above median its 10-year median of 2.56. The Drug Manufacturers industry median FCF Margin % is 2.45. Instituto Rosenbusch's value of 37.87% is 1448.9% above this industry median. Based on the distribution chart, Instituto Rosenbusch ranks #383 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Instituto Rosenbusch has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Instituto Rosenbusch's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Instituto Rosenbusch ranks #383 out of 958 companies for FCF Margin %. This puts Instituto Rosenbusch in the upper half of its industry. The industry median FCF Margin % is 2.45. Instituto Rosenbusch's value of 37.87% is 1448.9% above this benchmark. While the company's 10-year median is 2.56 vs. the industry median of 2.45, Instituto Rosenbusch has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Instituto Rosenbusch's current FCF Margin % of 37.87% is 1448.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Instituto Rosenbusch and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Instituto Rosenbusch's current FCF Margin % is 37.87%, which is 1379% above median its own 10-year median of 2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instituto Rosenbusch stock overvalued right now?
Based on GuruFocus' analysis, Instituto Rosenbusch (BUE:ROSE) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS61.70, compared to a current price of ARS162.00 — trading 162.6% above its estimated fair value. The current FCF Margin % is 37.87%, which is 1379% above median its 10-year median of 2.56 and 1448.9% above the Drug Manufacturers industry median of 2.45. Instituto Rosenbusch's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Instituto Rosenbusch (BUE:ROSE), the current FCF Margin % is 37.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?
Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued.
The current stock price of ARS162.00 is trading 162.6% above its estimated GF Value™ of ARS61.70.
GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.
Key valuation signals for BUE:ROSE:
FCF Margin %: 37.87% (1379% above median its 10-year median of 2.56)
GF Value™: ARS61.70 vs. price of ARS162.00 (162.6% above fair value)
Industry Position: 1448.9% above the Drug Manufacturers median (#383 of 958)
No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
39GF Score
Get the complete analysis for BUE:ROSE
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUE:ROSE has been successfully added to your 
